XACDURO (sulbactam for injection; durlobactam for injection) is a new treatment designed specifically to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex in adults. In this role, the Senior Director will provide active management of small molecule drug substance contract manufacturers worldwide to ensure the successful manufacture and tech transfer of drug substance processes supporting IST's commercial products as part of a virtual manufacturing organization.